![Michael Friedman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Friedman
No open positions remaining
Net worth: - $ as of 2026-07-30
Profile
Michael Friedman is currently Principal at EMERALD BIOVENTURES LLC since 2024.
Former roles include Director at Platform Equity LLC and Akari Therapeutics Plc, Independent Director at Peak Bio, Inc. from 2023 to 2024, Director at Galera Therapeutics, Inc. (US) from 2024 to 2026, and Senior Vice President at Ladenburg Thalmann & Co., Inc. from 2017 to 2023.
Education includes undergraduate studies at the University of Wisconsin and an MBA from The University of Chicago Booth School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 2026-08-02 | 0 ( -.--% ) | - $ | 2026-07-30 |
Michael Friedman active positions
| Companies | Position | Start |
|---|
Former positions of Michael Friedman
| Companies | Position | End |
|---|---|---|
| GALERA T COM USD0. | Director/Board Member | 2026-08-02 |
| PEAK BIO, INC. | Director/Board Member | 2024-07-18 |
Ladenburg Thalmann & Co., Inc.
 Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Corporate Officer/Principal | 2022-12-31 |
Platform Equity LLC
 Platform Equity LLC Investment ManagersFinance Platform Equity seeks investment opportunities in companies located US. The Firm targets companies operating in the fields of entertainment and Digital media sector and provide financing for seed,early and later stage capital requirements. | Private Equity Investor | 2008-05-31 |
| AKARI THERAPEUTICS, PLC | Director-Back Office Operation | - |
Training of Michael Friedman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
17
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Finance |
Platform Equity LLC
Platform Equity LLC Investment ManagersFinance Platform Equity seeks investment opportunities in companies located US. The Firm targets companies operating in the fields of entertainment and Digital media sector and provide financing for seed,early and later stage capital requirements. | Finance |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Peak Bio, Inc.
 Peak Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics to treat oncology and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Michael Friedman
